Diabetes

  • Two black, rounded devices next to each other give the same reading of 102 mg/dL.
    Image attribution tooltip
    Courtesy of Trividia Health
    Image attribution tooltip

    FDA advises users of Trividia glucometer to switch to alternatives

    The potential for error code confusion to cause delayed or improper treatment led the FDA to recommend users transition to other blood glucose meters.

    By • April 30, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem recalls Mobi insulin pumps over software malfunction

    A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.

    By • April 22, 2026
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendlineâž”
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed posts double-digit sales growth, widening net loss

    New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault wrote.

    By • April 21, 2026
  • A rectangular, metallic device on a catheter sites next to three nickels.
    Image attribution tooltip
    Permission granted by Glucotrack
    Image attribution tooltip

    Glucotrack plans US trial of implantable glucose monitor this year

    Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.

    By • March 27, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    Medtronic lowers earnings forecast after MiniMed IPO

    The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.

    By • March 25, 2026
  • Two green pens side by side
    Image attribution tooltip
    Retrieved from Owen Mumford on March 19, 2026
    Image attribution tooltip

    Embecta to buy Owen Mumford for up to $201M

    The planned purchase would allow Embecta to serve patients outside of diabetes care.

    By • March 19, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed gets FDA nod for smaller insulin pump

    MiniMed Flex is a smartphone-controlled insulin pump about half the size of MiniMed’s previous device. It’s the company’s first launch since separating from Medtronic in early March.

    By • March 18, 2026
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps

    The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause insulin to leak inside the pod.

    By • March 13, 2026
  • Professional photo of Ashley McEvoy
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet posts clinical data on fully closed-loop insulin delivery system

    The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

    By • March 12, 2026
  • Professional photo of Que Dallara
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic’s MiniMed goes public for $560M

    The diabetes tech business is now operating as a standalone, public company. Shares began trading on Friday.

    By • March 6, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA warns insulin infusion set maker Unomedical over leaks, mishandled complaints

    Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.

    By • March 2, 2026
  • A person sits on a couch with a white patch on their upper arm and a rectangular device with a screen on their hip.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    FDA warns Beta Bionics on unreported complaints, insulin pump changes

    The Food and Drug Administration warning letter detailed unreported low blood sugar and a software change to correct for delayed glucose readings.

    By • Feb. 26, 2026
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    AdvaMed names Jake Leach as chair of diabetes sector

    The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.

    By • Feb. 24, 2026
  • Professional photo of Que Dallara
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic’s MiniMed prices IPO at up to $784M

    The diabetes spinoff plans to offer 28 million shares at $25 to $28 each.

    By • Feb. 24, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to cut 81 employees at California diabetes site

    As Medtronic prepares to spin out its diabetes business, a spokesperson said the company is considering the structure, capabilities and scale needed to succeed.

    By • Feb. 20, 2026
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics launches automated insulin dosing system with 1-year CGM

    The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes. 

    By • Feb. 20, 2026
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes

    New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

    By • Feb. 13, 2026
  • Medtronic's MiniMed 780G
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins expanded FDA label for 780G insulin pump

    The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

    By • Feb. 5, 2026
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott receives FDA warning letter over Freestyle Libre CGMs

    Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.

    By • Feb. 3, 2026
  • A person sits on a couch with a white patch on their upper arm and a rectangular device with a screen on their hip.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics receives FDA warning letter

    The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute products, the company said.

    By • Feb. 2, 2026
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics wins CE mark for one-year CGM

    The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.

    By • Jan. 30, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • A person sits on a ledge with their legs in the water and eats. A patch is on their arm and a pen is on the ground next to food.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic gets FDA clearance for smart insulin pen app

    The app pairs Medtronic’s smart insulin pens with a sensor made by Abbott.

    By • Jan. 13, 2026
  • A person holds a phone, wearing a white patch on their forearm and an insulin pump on their hip.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s diabetes spinoff MiniMed files for IPO

    MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

    By • Dec. 22, 2025
  • A sign for the FDA is shown in front of the headquarters building in Silver Spring, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA pilots allowing digital health devices access to CMS payment program

    Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect real-world data in a CMS program.

    By • Dec. 10, 2025